| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 164.58B | 159.65B | 141.91B | 132.36B | 109.77B | 98.69B |
| Gross Profit | 45.73B | 42.75B | 37.21B | 35.64B | 31.02B | 26.80B |
| EBITDA | 26.41B | 23.90B | 19.52B | 18.14B | 15.77B | 13.30B |
| Net Income | 15.76B | 13.89B | 12.16B | 11.02B | 8.55B | 6.25B |
Balance Sheet | ||||||
| Total Assets | 206.06B | 199.22B | 187.46B | 167.79B | 155.49B | 144.70B |
| Cash, Cash Equivalents and Short-Term Investments | 38.05B | 51.92B | 46.93B | 39.87B | 39.59B | 42.63B |
| Total Debt | 8.60B | 10.42B | 18.90B | 25.91B | 29.87B | 34.56B |
| Total Liabilities | 53.20B | 55.34B | 62.77B | 62.01B | 63.65B | 63.80B |
| Stockholders Equity | 152.39B | 143.37B | 124.14B | 105.08B | 91.23B | 80.24B |
Cash Flow | ||||||
| Free Cash Flow | 9.82B | 14.88B | 9.24B | 4.62B | 2.18B | 9.91B |
| Operating Cash Flow | 18.77B | 20.54B | 13.49B | 12.94B | 9.71B | 12.96B |
| Investing Cash Flow | -16.69B | -11.81B | -5.28B | -9.61B | -8.65B | -1.89B |
| Financing Cash Flow | -7.79B | -7.80B | -7.05B | -7.01B | -6.62B | 12.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥140.61B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
78 Outperform | ¥173.29B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥998.68B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
74 Outperform | ¥111.68B | 13.53 | ― | 2.66% | 7.56% | -17.12% | |
66 Neutral | ¥116.91B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.73T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |